Author Topic: A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer  (Read 779 times)

0 Members and 1 Guest are viewing this topic.

Offline feedbot

  • Επίλεκτο μέλος
  • *****
  • Posts: 6686
  • Κάπνισμα: Δεν κάπνισα ποτέ
A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer
     


The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.<br/><br/>    <a href="http://www.pheedo.com/click.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/06/01/health/research/01cancer.html"><img src="http://www.pheedo.com/img.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/06/01/health/research/01cancer.html" border="0"/></a>

     

http://www.nytimes.com/2008/06/01/health/research/01cancer.html?partner=rssnyt&emc=rss